Cooper C. Collins - 17 Jul 2023 Form 4 Insider Report for TherapeuticsMD, Inc. (TXMD)

Role
Director
Signature
/s/ Cooper C. Collins
Issuer symbol
TXMD
Transactions as of
17 Jul 2023
Net transactions value
$0
Form type
4
Filing time
19 Jul 2023, 17:27:06 UTC
Previous filing
03 Oct 2022
Next filing
23 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TXMD Restricted Stock Units Award $0 +8,500 $0.000000 8,500 17 Jul 2023 Common Stock 8,500 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. The RSU's will vest on July 17, 2024.